https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48692 Tue 28 Mar 2023 20:45:40 AEDT ]]> Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49563 0.05). After adjustment for demographic differences, participants who smoked had lower craving [b (SE) = −1.1 (0.5), P = 0.021] and were less likely to report psychotic symptoms [b (SE) = −1.8 (0.7), P = 0.013] or antidepressant use [b (SE) = −1.1 (0.5), P = 0.022]. Discussion and Conclusions: Smoking crystalline methamphetamine is associated with a younger less marginalised demographic profile than injecting methamphetamine, but a similarly severe clinical profile.]]> Mon 22 May 2023 09:20:09 AEST ]]> QuitNic: A Pilot Randomized Controlled Trial Comparing Nicotine Vaping Products with Nicotine Replacement Therapy for Smoking Cessation following Residential Detoxification https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49500 Fri 19 May 2023 12:08:56 AEST ]]> Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49822 Fri 02 Jun 2023 16:30:17 AEST ]]>